Rumor: Sam Altman backs Pharia Health, transcranial magnetic stimulation (TMS) protocol startup
The company targets high-performing professionals, pairing FDA-cleared TMS with d-cycloserine and optional $200 per month maintenance sessions.
By Ryan Merket · Published

The company targets high-performing professionals, pairing FDA-cleared TMS with d-cycloserine and optional $200 per month maintenance sessions.